The U.S. Food and Drug Administration granted accelerated approval for Novartis AG’s Agriflu to prevent disease caused by influenza virus subtypes A and B in adults ages 18 years and older.
Merck & Co., Inc. has entered into an exclusive agreement with CSL Biotherapies to market and distribute Afluria, CSL’s seasonal influenza vaccine in the U.S.
More than 50 percent of healthcare executives say lapses in the supply chain prevent their companies to respond quickly to pandemics.